Medtronic received information that the medtronic flow diverter pushwire fractured.Prior to the event, the medtronic microcatheter was placed in the m1 segment of the middle cerebral artery (mca) and then the flow diverter was pushed in the cavernous sinus and large resistance was felt.The flow diverter was finally able to reach the m1 segment, but the pushwire could only be pushed to the tip of the microcatheter and could not be pushed out any further.The entire system (flow diverter and microcatheter ) were withdrawn to the internal carotid artery (ica) and that was when the physician noticed that the pushwire had fractured and the flow diverter braid remained in the microcatheter when the whole part was withdrawn.The physician decided to terminate the treatment.The patient was undergoing embolization treatment of a unruptured saccular aneurysm measuring 11.69mm x 6.35mm located in the ophthalmic segment of the left internal carotid artery (ica).The distal and proximal landing zone was 3.45mm x 4.48mm.The patient¿s vasculature was moderate in tortuosity.It was unknown if the patient was on dual antiplatelet therapy.There are no images for review.
|
A4- patient information - weight = additional information h10.Additional manufacturer narrative - additional information, device evaluation the device will not be returned for investigation; however images were provided for review.In image the pipeline flex embolization device appears to be within the medtronic catheter.The pipeline flex pushwire appears to be protruding from within the catheter hub for an undeterminable length.What appears to be the pipeline flex tip coil is seen protruding from within the catheter distal tip.Based on the image provided the customer's reports of "pushwire break" could not be confirmed.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|